{"public_id":"cl_7534d473c26758faf3fc9f296bdc7dc5","status":"active","superseded_by_public_id":null,"corpus_id":6793687,"text":"HOP produced 61% complete remissions and 88% overall responses in 216 evaluable patients with advanced non-Hodgkin's lymphoma.","confidence":0.99,"paper":{"corpus_id":6793687,"title":"Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma","url":"https://sah.borca.ai/papers/6793687"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.99,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_6080da420699c430035fc815b9018508","name":"advanced non-Hodgkin's lymphoma","description":"A pathologically staged advanced form of non-Hodgkin's lymphoma treated with the reported regimens.","types":["disease"],"url":"https://sah.borca.ai/concepts/co_6080da420699c430035fc815b9018508"},{"public_id":"co_920024d341e9de6606bc2e6ad6da3a94","name":"complete remission","description":"A treatment outcome in which no detectable disease remains.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_920024d341e9de6606bc2e6ad6da3a94"},{"public_id":"co_c47f7bbb05afeeadd9ead4291556da02","name":"HOP","description":"A combination chemotherapy regimen containing Adriamycin, vincristine, and prednisone.","types":["chemotherapy regimen"],"url":"https://sah.borca.ai/concepts/co_c47f7bbb05afeeadd9ead4291556da02"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_7534d473c26758faf3fc9f296bdc7dc5"}